Skip Navigation

Cardiovascular Research 2000 48(3):367-374; doi:10.1016/S0008-6363(00)00194-2
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Klein, G.
Right arrow Articles by Schröder, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, G.
Right arrow Articles by Schröder, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Protein kinase G reverses all isoproterenol induced changes of cardiac single L-type calcium channel gating

Gunnar Klein, Helmut Drexler and Frank Schröder*

Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany

* Corresponding author. Tel.: +49-511-532-3841; fax: +49-511-532-5412 schroeder.f{at}mh-hannover.de

Objective: cGMP reduces the effect of β-adrenoceptor agonists on cardiac L-type calcium current by protein kinase G activation. Stimulation of β-adrenoceptors increases protein kinase A dependent phosphorylation of L-type calcium channels via cAMP. At the single channel level, protein kinase A dependent phosphorylation increases both availability and open probability. The present study investigates how cGMP antagonises protein kinase A induced changes of single L-type calcium channel gating. Methods: Single L-type calcium channels were recorded in the cell attached configuration of the patch clamp technique in isolated mouse ventricular myocytes. Results: The β-adrenoceptor agonist isoproterenol (10–6 M) enhanced single channel peak average current by increasing availability and open probability and decreasing the time constant of long close times. 8-Br-cGMP (10–3 M) completely reversed these effects. The phosphatase inhibitor okadaic acid (10–6 M) did not influence the effect of 8-Br-cGMP. The protein kinase G inhibitor Rp-8Br-PET-cGMPS (10–7 M) abated the effect of 8-Br-cGMP. Activation of protein kinase A by the hydrolysis-resistant cAMP derivative 8-Br-cAMP (10–3 M) enhanced L-type calcium channel activity like isoproterenol and its effect was also reversed by 8-Br-cGMP. Conclusion: 8-Br cGMP diminishes β-adrenoceptor activation of L-type calcium channels via protein kinase G. It interacts with the β-adrenoceptor signaling pathway distal of adenylyl cyclase. Our observations suggest that protein kinase G interacts either with protein kinase A or directly with the L-type calcium channel.

KEYWORDS Signal transduction; Protein kinases; Adrenergic (ant)agonists; Ca-channel; Myocytes; Single channel currents


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wang, M. J. Kohr, D. G. Wheeler, and M. T. Ziolo
Endothelial nitric oxide synthase decreases {beta}-adrenergic responsiveness via inhibition of the L-type Ca2+ current
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1473 - H1480.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A.G. van der Heyden, T. J.M. Wijnhoven, and T. Opthof
Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels
Cardiovasc Res, January 1, 2005; 65(1): 28 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Sengenes, A. Bouloumie, H. Hauner, M. Berlan, R. Busse, M. Lafontan, and J. Galitzky
Involvement of a cGMP-dependent Pathway in the Natriuretic Peptide-mediated Hormone-sensitive Lipase Phosphorylation in Human Adipocytes
J. Biol. Chem., December 5, 2003; 278(49): 48617 - 48626.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Groschner
NO and cholinergic signalling in the heart: divergent routes to regulatory phosphorylation of the cardiac L-type Ca2+ channel
Cardiovasc Res, November 1, 2003; 60(2): 223 - 225.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Schroder, G. Klein, B. Fiedler, M. Bastein, N. Schnasse, A. Hillmer, S. Ames, S. Gambaryan, H. Drexler, U. Walter, et al.
Single L-type Ca2+ channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice
Cardiovasc Res, November 1, 2003; 60(2): 268 - 277.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Klein, F. Schroder, D. Vogler, A. Schaefer, A. Haverich, B. Schieffer, T. Korte, and H. Drexler
Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation: Role of phosphatase 2A
Cardiovasc Res, July 1, 2003; 59(1): 37 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. A. Birder, M. L. Nealen, S. Kiss, W. C. de Groat, M. J. Caterina, E. Wang, G. Apodaca, and A. J. Kanai
beta -Adrenoceptor Agonists Stimulate Endothelial Nitric Oxide Synthase in Rat Urinary Bladder Urothelial Cells
J. Neurosci., September 15, 2002; 22(18): 8063 - 8070.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Fiedler, S. M. Lohmann, A. Smolenski, S. Linnemuller, B. Pieske, F. Schroder, J. D. Molkentin, H. Drexler, and K. C. Wollert
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes
PNAS, August 20, 2002; 99(17): 11363 - 11368.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-B. Shen and A. J. Pappano
On the Role of Phosphatase in Regulation of Cardiac L-Type Calcium Current by Cyclic GMP
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 501 - 506.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.